BayBio Partners

BioBasics Workshop - November 2011

Nov 17, 2011 - Nov 18, 2011 - Category: BayBio Event

Learn the basics of biotechnology by skilled and experienced industry scientists. Join other non-science professionals and gain a thorough understanding of the science, technology and terminology which form the foundation of the biotechnology industry. Click here for the class agenda.

What: BioBasics Workshop
Industry Knowledge for the Non-Scientist
Course Outline
Biotech: The Basics
When: November 17-18, 2011
9:00am - 4:30pm
Where: Latham & Watkins
140 Scott Drive
Menlo Park, CA 94025
Directions
Parking: Ample parking available at no cost in the employee lot
This Event is Sold Out

BioBasic deliverables include:

A reference manual is packed with copies of the presentation slides, additional scientific information, and a glossary of biotech terms. A light breakfast and lunch are provided. Course Outline.

Why Attend?

"The biotechnology industry moves so rapidly that it is vital for members of our staff to have not only a strong grasp on the basics of the life sciences, but also an understanding of how the latest developments in the field affect our business. BioTech Primer's course provided more than just a base of learning and enabled our leadership team to grasp bigger concepts of how our technologies work both together and for our customers." Greg Lucier, Chairman and CEO, Invitrogen Corporation, San Diego, CA.

Questions? Contact us by phone: 650-871-7101 x205 or by e-mail: events@baybio.org

Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!

Therapeutics Series Sponsors

Start Date: Nov 17, 2011. 09:00 AM
End Date: Nov 18, 2011. 04:30 PM
Location: Latham & Watkins
Address: 140 Scott Drive, Menlo Park, CA, 94025, United States
Cost: BayBio Members: $845 Non-Member: $945
Contact BayBioWeb Site Terms and Conditions
BayBio • 400 Oyster Point Blvd. Suite 221 • South San Francisco, CA 94080 • Tel: (650) 871-7101
Printable Version
Custom Web Development by the New Possibilities Group